Key result
SGLT-2 inhibitors significantly decreased stretch-induced cell permeability and reactive oxygen species production in human coronary artery endothelial cells.
Why the study?
Although SGLT-2 inhibitors show anti-oxidative effects in resting endothelial cells, their ability to alleviate cyclic stretch-induced endothelial permeability remained unknown.
Do SGLT-2 inhibitors reduce cyclic stretch-induced endothelial permeability and ROS production in human coronary artery endothelial cells?
Do SGLT-2 inhibitors reduce cyclic stretch-induced endothelial permeability and ROS production in human coronary artery endothelial cells?
SGLT-2 inhibitors ameliorate stretch-induced endothelial barrier dysfunction in human coronary artery endothelial cells, likely through ROS scavenging and inhibition of NHE1 and NOXs.
Answers are grounded in this paper and cite their sources.
In vitro SGLT2i endothelial protection under stretch; leaves open clinical vascular relevance pending in vivo confirmation.
SGLT-2i's exert direct anti-inflammatory and anti-oxidative effects on resting endothelial cells. However, endothelial cells are constantly exposed to mechanical forces such as cyclic stretch. Enhanced stretch increases the production of reactive oxygen species (ROS) and thereby impairs endothelial barrier function. We hypothesized that the SGLT-2i's empagliflozin (EMPA), dapagliflozin (DAPA) and canagliflozin (CANA) exert an anti-oxidative effect and alleviate cyclic stretch-induced endothelial permeability in human coronary artery endothelial cells (HCAECs). HCAECs were pre-incubated with one of the SGLT-2i's (1 µM EMPA, 1 µM DAPA and 3 µM CANA) for 2 h, followed by 10% stretch for 24 h. HCAECs exposed to 5% stretch were considered as control. Involvement of ROS was measured using N-acetyl-l-cysteine (NAC). The sodium-hydrogen exchanger 1 (NHE1) and NADPH oxidases (NOXs) were inhibited by cariporide, or GKT136901, respectively. Cell permeability and ROS were investigated by fluorescence intensity imaging. Cell permeability and ROS production were increased by 10% stretch; EMPA, DAPA and CANA decreased this effect significantly. Cariporide and GKT136901 inhibited stretch-induced ROS production but neither of them further reduced ROS production when combined with EMPA. SGLT-2i's improve the barrier dysfunction of HCAECs under enhanced stretch and this effect might be mediated through scavenging of ROS. Anti-oxidative effect of SGLT-2i's might be partially mediated by inhibition of NHE1 and NOXs.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied Endothelium barrier dysfunction. SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) vs. HCAECs exposed to 5% stretch was evaluated on Cell permeability and reactive oxygen species (ROS) production. SGLT-2 inhibitors significantly decreased stretch-induced cell permeability and reactive oxygen species production in human coronary artery endothelial cells.
Synapse has enriched 10 related papers. Consider them for comparative context: